NASDAQ:GBT
Global Blood Therapeutics, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Selectwebsite
www.gbt.comipo date
Aug 12, 2015full time employees
457currency
USD
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety an...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus